African Journal of
Microbiology Research

  • Abbreviation: Afr. J. Microbiol. Res.
  • Language: English
  • ISSN: 1996-0808
  • DOI: 10.5897/AJMR
  • Start Year: 2007
  • Published Articles: 4983

Full Length Research Paper

Predisposing factors and cost Implications of pulmonary tuberculosis in patients attending federal medical centre Makurdi, Nigeria

O. Vange
  • O. Vange
  • Department of Biological Sciences, University of Agriculture Makurdi, Benue State, Nigeria.
  • Google Scholar
E. U. Umeh
  • E. U. Umeh
  • Department of Biological Sciences, University of Agriculture Makurdi, Benue State, Nigeria.
  • Google Scholar
E. T. Azua
  • E. T. Azua
  • Department of Biological Sciences, University of Agriculture Makurdi, Benue State, Nigeria.
  • Google Scholar


  •  Received: 03 October 2017
  •  Accepted: 05 March 2018
  •  Published: 30 September 2019

References

Ahlburg DA (2000). The Economic Impacts of Tuberculosis. In The STOP TB Initiative 2000 Series. Amsterdam: Word Health Organization; 32p.

 

Ataguba JE (2011). Reassessing Catastrophic Health-Care Payments with a Nigerian Case Study. Health Economics. Policy. Law. 18.
Crossref

 
 

Barter DM, Agboola SO, Murray MB, and Bärnighausen T (2012). Tuberculosis and Poverty: The Contribution of Patient Costs in Sub-Saharan Africa-A Systematic Review BMC 12:980.
Crossref

 
 

Collins D, Beyene D, Tedla Y, Diro E, Mesfin H, Levin A (2013). Costs faced by multi-drug resistant tuberculosis patients during diagnosis and treatment. Report from a pilot study in Ethiopia. Cambridge, MA, USA: TB CARE I-Management Sciences for Health.

 
 

Dim CC, and Dim NR (2013). Trends of Tuberculosis Prevalence and Treatment Outcome in an Under-resourced Setting: The Case of Enugu State, South East Nigeria. Nigerian Medical Journal 54:392-7
Crossref

 
 

Drummond MF, Schulpher MJ, Torrance GW, O'Brien BJ, Stoddart GL (2007). Basic Types of Economic Evaluation. In: Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, New York, P 24.

 
 

Elender F, Bentham G, and Langford I (1998). Tuberculosis Mortality in England and Wales during 1982-1992: Its Association with Poverty, Ethnicity and AIDS. Social Science and Medicine 46(6):673-681.
Crossref

 
 

Fabricant SJ, Kamara CW, and Mills A (1999). Why The Poor Pay More: Household Curative Expenditures in Rural Sierra Leone. The International Journal of Health Planning and Management 14:179-199.
Crossref

 
 

Foster N, Vassal A, and Sinanovic E (2015). The Economic Burden of TB Diagnosis and Treatment in South Africa. Social Science and Medicine 130:42-50.
Crossref

 
 

Hansel NN, Wu AW, Chang B, Diette GB (2004). Quality of Life in Tuberculosis: Patient and Provider Perspectives. International Journal of Quality of Life Aspects of Treatment, Care Rehabilitation 13(3):639-652.
Crossref

 
 

Kemp JR, Mann G, Simwaka BN (2007). Can Malawi's poor afford free tuberculosis services. Patient and Household Costs Associated with a
Crossref

 
 

Tuberculosis Diagnosis in Lilongwe. Bulletin of the World Health Organization 85:580-585.

 
 

Kumar V, Abbas AK, Fausto N, Mitchell RN (2007). Robbins Basic Pathology, 8th edition. Philadelphia, USA, Saunders Elsevier 39-42.

 
 

Laokri S, Drabo ML, Weil O, Kafando B, Dembélé SM, and Dujardin B (2013).Patients Are Paying Too Much for Tuberculosis: A Direct Cost-Burden Evaluation in Burkina Faso. PLoS One 8(2)56752.
Crossref

 
 

Lonnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, Raviglione MC (2010).Tuberculosis Control and Elimination. 2010-50: Cure, Care, and Social Development. The Lancet 375(9728):1814-1829.
Crossref

 
 

Nigerian Medical Association (NMA) (2013). 27,000 Nigerians Die of Tuberculosis Yearly. 'Retrieved from' 

View. Accessed on 22 APRIL, 2014.

 
 

Oxlade O, Murray M (2012). Tuberculosis and poverty: why are the poor at greater risk in India? PLoS One 7:47533,
Crossref

 
 

Paton NI, Ng YM (2006). Body Composition Studies in Patients with Wasting Associated with Tuberculosis. Nutrition (Burbank, Los Angeles County, California) 22(3):245-251
Crossref

 
 

Peter R, Donald B, Chan M, and Paul D (2009). The global burden of tuberculosis-combating drug resistance in difficult times. The New England Journal of Medicine 360:2393-2395.
Crossref

 
 

Rundi C (2010). Understanding Tuberculosis: Perspective and Experiences of the people of Sabah, East Malaysia. Journal of Health, Population and Nutrition 28(2):114-123.
Crossref

 
 

Russell S (2004). The economic burden of illness for households in developing countries: A review of studies focusing on malaria, tuberculosis, and human immunodeficiency virus/acqiured immunodeficiency syndrome. The American Journal of Tropical Medicine and Hygiene 71(4):147-155.
Crossref

 
 

Sagbakken M, Frich J, and Bjune G (2008). Barriers and Enablers in the Management of Tuberculosis Treatment in Addis Ababa, Ethiopia: A Qualitative Study. BMC Public Health 8:11.
Crossref

 
 

Sanou A, Dembele M, Theobald S, Macq J (2004). Access and Adhering to Tuberculosis Treatment: Barriers Faced by Patients and Communities in Burkina Faso. International Journal of Tuberculosis and Lung Disease 8:1479-1483.

 
 

Tony TO, Odunayo OO, Victor A A (2015). A Retrospective Study of the Incidence of Pulmonary Tuberculosis and Human Immunodeficiency Virus Co-Infection among Patients Attending National Tuberculosis and Leprosy Control Programme, Owo Centre. Pamj 20 345.
Crossref

 
 

Ukwaja KN, Alobu I, lgwenyi C, Hopewell PC (2013). The high cost of free tuberculosis services: Patient and household costs associated with tuberculosis care in Ebonyi tate, Nigeria.
Crossref

 
 

Ukwaja KN, Modebe O, Igwenyi C, Alobu I (2012). The Economic Burden of Tuberculosis Care for Patients and Households in Africa: A Systematic Review. International Journal of Tuberculosis and Lung Disease 16:733-739.
Crossref

 
 

Umar N, Abubakar I, Fordham R, Bachmann M (2012). Direct Costs of Pulmonary Tuberculosis among Patients Receiving Treatment in Bauchi State, Nigeria. International Journal of Tuberculosis and Lung Disease 16:835-840.
Crossref

 
 

Whitehead M, Dahlgren G, Evans T (2001). Equity and health sector reforms: can low-income countries escape the medical poverty trap? Lancet 358:833-836.
Crossref

 
 

World Health Organization (WHO) (2005). Anti-Tuberculosis Drug Resistance in the World: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Report No. 3. Prevalence and Trends. WHO/HTM/TB/2004.343. Geneva, Switzer-land.

 
 

World Health Organization (WHO) (2009). Epidemiology. Global tuberculosis control: epidemiology, strategy, financing mates of TB burden.6-33. PubMed | Google Scholar.

 
 

World Health Organization (WHO) (2010). Tuberculosis. In: Raviglione Mario C., editor. The Essentials. Fourth Edition. Geneva Switzerland: World Health Organization. 

View

 
 

World Health Organization (WHO) (2011). WHO report: Global tuberculosis control. Geneva, Switzerland: WHO; WHO/HTM/TB/2011.16.

 
 

World Health Organization (WHO) (2012). Group of risk. WHO global tuberculosis report. 

View

 
 

World Health Organization (WHO) (2013a). WHO Country Cooperation Strategy 2012-2015. Ethiopia: WHO Regional Office for Africa, Republic of Congo.

View

 
 

World Health Organization (WHO) (2013b). Global Tuberculosis Control. WHO Report 2013, Geneva.

 
 

Wingfield V, Boccia V, Tovar V, Gavino A, Zevallos K, Montoya R, Lönnroth K, Evans C (2014). Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru. Plos Medicine 11(7):e1001675
Crossref

 
 

Zumla A, Mario R, Richard H, Fordham C (2013). Tuberculosis. The New England Journal of Medicine 368:745-55.
Crossref